Danaher Corporation (VIE:DHRC)

Market Cap	117.81B -14.9%
Revenue (ttm)	20.92B +2.9%
Net Income	3.08B -7.3%
EPS	4.30 -4.5%
Shares Out	n/a
PE Ratio	38.28
Forward PE	22.57
Dividend	1.17 (0.70%)
Ex-Dividend Date	Mar 27, 2026

Volume	n/a
Average Volume	4
Open	163.34
Previous Close	164.94
Day's Range	163.34 - 166.02
52-Week Range	153.52 - 208.00
Beta	n/a
RSI	45.15
Earnings Date	Apr 21, 2026

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufact...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 59,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: DHRC

Financial Performance

In 2025, Danaher's revenue was $24.57 billion, an increase of 2.90% compared to the previous year's $23.88 billion. Earnings were $3.61 billion, a decrease of -7.31%.

Financial numbers in USD